Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug. (Q44051266)
Jump to navigation
Jump to search
scientific article published in April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug. |
scientific article published in April 2014 |
Statements
Randomised, double-blind, placebo-controlled, dose-escalating phase I study of QGC001, a centrally acting aminopeptidase a inhibitor prodrug (English)
Fabrice Balavoine
Michel Azizi
Damien Bergerot
Nadia De Mota
Rémi Patouret
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference